1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Diabetes and other endocrinal, nutritional and metabolic conditions
  5. Osteoporosis

Raloxifene for the primary prevention of osteoporotic fragility fractures in postmenopausal women

Technology appraisal guidance [TA160] Published: 27 October 2008 Last updated: 07 February 2018

  • Guidance
  • Tools and resources
  • Evidence
  • History

Tools and resources

Tools to help you put the guidance into practice.

Education

  • Slide set PowerPoint 2.13 MB 10 December 2008  

Shared learning

  • Shared learning information  

Do not do

  • Do not do information  

Guidance into practice

  • About the Into practice guide  
  • Practical steps to improving the quality of care and services using NICE guidance